The goal of the trial was to assess the safety and efficacy of icosapent ethyl (IPE) on reducing infection rate among participants at high risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The trial took place under the observation of the Government of Argentina and CCLA.org (a Non-Profit Organization in Canada).
Patient Register - The Covid suffered or ongoing covid patients were registered for trial and they were provided medication. Then, doctors checked the pros and cons of the medication and record the data on the data list “Prepare - IT”
Our case studies
See all projects
WhatsApp Chatbot for Student Helpdesk for Karnataka's Education Ministry
WhatsApp Chatbot for Covid-19 Helpline in Punjab and Assam Government.
IVR Service in Punjab to spread Safety Instructions plus Helpline from Covid-19.
One of the Biggest E-Commerce Store App in Argentina.